Trial of Solanezumab in Preclinical Alzheimer’s DiseaseReisa A. Sperling, Paul Aisen, Michael Donohue et al.|New England Journal of Medicine|2023Cited by 382
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migrainePeter J. Goadsby, Charly Gaul, Michael Case et al.|Brain|2019Cited by 275